Drug-resistant pathogens pose a global challenge to public health as they cause diseases
that are extremely difficult to cure. Metallo-β-lactamases (MBLs) are a diverse set of zinc …

Abstract Metallo-β-lactamases (MBLs) are a group of Zn (II)-dependent enzymes that pose a
major threat to global health. They are linked to an increasing number of multi-drug resistant …

The emergence of metallo-β-lactamases (MBLs) confers resistance to nearly all the β-lactam
antibiotics, including carbapenems. Currently, there is a lack of clinically useful MBL …

Abstract Metallo‐β‐lactamases (MBLs) are zinc‐dependent bacterial enzymes that
inactivate essentially all classes of β‐lactam antibiotics including last‐resort carbapenems …

As one of important mechanisms to β-lactam antimicrobial resistance, metallo-β-lactamases
(MBLs) have been receiving increasing worldwide attentions. Ambler subclass B1 MBLs are …

Antimicrobial resistance is a global public health threat. Metallo-β-lactamases (MBLs)
inactivate β-lactam antibiotics, including carbapenems, are disseminating among Gram …

ABSTRACT Introduction Metallo-β-lactamases (MBLs) are enzymes produced by bacteria
that confer resistance to most β-lactam antibiotics, including carbapenems, which have the …

Metallo-β-lactamases (MBLs) are zinc-dependent enzymes capable of hydrolyzing all
bicyclic β-lactam antibiotics, posing a great threat to public health. However, there are …

Abstract Metallo‐β–lactamases (MBLs) are zinc‐containing carbapenemases that inactivate
a broad range of β–lactam antibiotics. There is a lack of β–lactamase inhibitors for restoring …

Metallo-β-lactamases (MBLs) are a family of Zn (II)-dependent enzymes that can hydrolyze
almost all β-lactam antibiotics. Horizontal transfer of the genes encoding MBLs among Gram …